Regulation and Products

Share

In 2009, we won a hard-fought campaign that led to Congress passing a law granting the U.S. Food and Drug Administration (FDA) the authority to regulate all tobacco products, including cigarettes, e-cigarettes, cigars and hookah. Yet, it took the FDA seven years to begin their oversight of many of these products with much more work left to be done. 

Recent spikes in the use of e-cigarettes makes clear that more must be done to regulate tobacco products and the industry's deceptive marketing practices.  We are working to ensure the government fully leverages the regulatory power it now possesses to protect children and adults. 

Tobacco use costs our nation nearly $300 billion in health care and productivity losses each year.

Take Action

Big Win Against Big Tobacco

It's time to end the youth e-cigarette vaping epidemic

We need Congress to choose kids and families over Big Tobacco and the e-cigarette industry.

Latest Updates

April 23, 2020
Maine

Victory in the fight against cancer requires bold new public policies that promote cancer prevention, early detection of cancer, and expand access to quality, affordable health care. Lawmakers make many decisions that impact the lives of Mainers touched by cancer and their leadership is vital to defeating this disease. In

April 17, 2020
Idaho

Idaho’s 2020 legislative session has come to an end. While the American Cancer Society Cancer Action Network (ACS CAN) did not have a major legislative victory during the session, there is certainly a lot of positive news that we can report. The session ended with growing concern about COVID-19 and

February 27, 2020
Oregon

SALEM, Ore.— Cancer patients, survivors and their loved ones convened at the State Capitol today, February 27, for the annual Cancer Action Day at the Capitol, hosted by the American Cancer Society Cancer Action Network (ACS CAN). February is National Cancer Prevention Month and the group spent the day-long event

February 5, 2020
National

The House Energy and Commerce Subcommittee on Oversight and Investigations holds a hearing on e-cigarette use in the United States amid an ongoing youth tobacco epidemic and one day before the US Food and Drug Administration (FDA) is set to begin enforcement of the agency’s weak guidance released in early January that put industry profits above the health of children.

Regulation and Products Resources

Our organizations are writing in connection with the April 30 action by the U.S. Food and Drug Administration (FDA) issuing a marketing order to Philip Morris International (PMI) and Philip Morris Products S.A. allowing the U.S. marketing of IQOS heated tobacco products, to be distributed in the U.S. exclusively by Altria Client Services LLC (Altria).

The undersigned public health organizations submit these comments on the above-listed amended tobacco product modified risk applications submitted by Swedish Match North America, Inc. (“Swedish Match”) for multiple snus products (“General snus”). The subject applications should be denied for the reasons detailed in these comments.

We write to urge the Food and Drug Administration (FDA) to conduct a thorough investigation of, and take appropriate enforcement action against, the marketing of JUUL e-cigarettes with express or implied claims that the products help users stop smoking.